
FDA Advisory Committee Votes Against Recommending Brexpiprazole Plus Sertraline for PTSD
The US Food and Drug Administration Advisory Committee voted not to recommend brexpiprazole (Rexulti) in combination with sertraline for posttraumatic stress disorder (PTSD). The panel believed the efficacy was not well-enough established to recommend its …